Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$444K Buy
817
+121
+17% +$62.2K 0.01% 610
2026
Q1
$302K Buy
696
+44
+7% +$19.4K ﹤0.01% 735
2025
Q4
$214K Sell
652
-3
-0.5% -$964 ﹤0.01% 894
2025
Q3
$209K Buy
+655
New +$181K ﹤0.01% 891

Other funds holding NVMI

Ballentine Partners's NVMI Position: Q2 2026 in Review

Ballentine Partners increased its Nova (NVMI) stake by 17% in Q2 2026, buying an estimated $62.2K and bringing the position to 817 shares worth $444K. The position accounts for 0.01% of the portfolio, ranked #610.

Ballentine Partners first reported a position in NVMI in Q3 2025 and has held it in 4 quarters since. 39 funds tracked by Wall St. Rank hold NVMI as of Q2 2026.

  • Ballentine Partners held 817 shares of Nova worth $444K as of Q2 2026.
  • Ballentine Partners bought 121 Nova shares in Q2 2026, an estimated $62.2K.
  • Nova made up 0.01% of Ballentine Partners's portfolio in Q2 2026, its #610 holding.
  • Ballentine Partners first reported a position in Nova in Q3 2025 and has held it in 4 quarters since.
  • 39 funds tracked by Wall St. Rank held Nova as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.